TH59782A3 - Controlled release galantamine mixtures - Google Patents
Controlled release galantamine mixturesInfo
- Publication number
- TH59782A3 TH59782A3 TH9901004862A TH9901004862A TH59782A3 TH 59782 A3 TH59782 A3 TH 59782A3 TH 9901004862 A TH9901004862 A TH 9901004862A TH 9901004862 A TH9901004862 A TH 9901004862A TH 59782 A3 TH59782 A3 TH 59782A3
- Authority
- TH
- Thailand
- Prior art keywords
- mixtures
- controlled release
- galantamine
- acceptable
- pharmaceutical field
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title claims abstract 10
- 229960003980 galantamine Drugs 0.000 title claims abstract 5
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title claims abstract 5
- 239000000203 mixture Substances 0.000 title claims abstract 5
- 238000013270 controlled release Methods 0.000 title abstract 3
- 230000001105 regulatory effect Effects 0.000 claims abstract 3
- HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 claims abstract 2
- LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 claims abstract 2
- IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000020477 pH reduction Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Abstract
DC60 (10/02/43) การประดิษฐ์นี้เกี่ยวกับสารผสมชนิดปลดปล่อยที่มีการควบคุมสำหรับการให้โดยทางปาก ซึ่ง ประกอบรวมด้วยกาแลนแทมีน ; และเกี่ยวกับกรรมวิธีของการเตรียมสารผสมชนิดปลดปล่อยที่มี การ ควบคุมดังกล่าว การประดิษฐ์นี้เกี่ยวกับสาราผสมชนิดปลดปล่อยที่มีการควบคุมสำหรับการให้โดยทางปาก ซึ่ง ประกอบรวมด้วยกาแลนแทมีน ; และเกี่ยวกับกรรมวิธีของการเตรียมสารผสมชนิดปลดปล่อยที่มี การ ควบคุมดังกล่าว สิทธิบัตรยา DC60 (10/02/43) This invention deals with regulated release mixtures for oral administration consisting of galantamine; And regarding the process of preparing such controlled release mixtures. The invention is about a controlled release compound for oral administration consisting of galanthamine; And about the process of preparing such regulated release mixtures, drug patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH59782A3 true TH59782A3 (en) | 2003-12-04 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1117383T3 (en) | Dosage forms comprising therapeutic formulation | |
| BRPI0015567B8 (en) | compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition | |
| FR11C0017I2 (en) | Use of spinosad or a formulation comprising spinosad | |
| EA200600484A1 (en) | DELIVERY OF PHYSIOLOGICAL AGENTS IN SITU WITH THE HELP OF GELS, INCLUDING ANIONAL POLYSACCHARIDES | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| BR0008590A (en) | Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed | |
| CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
| YU66600A (en) | Pharmaceutical compositions capable of being gelled | |
| ATE387430T1 (en) | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS | |
| DE60211130D1 (en) | NEW FORMULATION WITH MODIFIED RELEASE | |
| HUP0105173A2 (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| ATE396967T1 (en) | (5-(2-HYDROXY-4-CHLOROBENZOYL)VALERIC ACID AND SALTS THEREOF, AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS CONTAINING THESE COMPOUNDS | |
| AR038947A1 (en) | ORAL SUSPENSION OF NICE FLAVOR AND METHOD | |
| ATE158504T1 (en) | EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS | |
| WO2002045686A3 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
| CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
| ES2186207T3 (en) | METHOD FOR PREPARATION OF PHARMACEUTICAL FORMULATIONS. | |
| CA2380757A1 (en) | Pharmaceutical agent comprising a benzamide derivative as active ingredient | |
| NZ331083A (en) | Pharmaceutical preparations of cilansetron stabilized against racemization | |
| WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
| WO1999047172A3 (en) | Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes | |
| TH59782A3 (en) | Controlled release galantamine mixtures | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| EP1634585A4 (en) | PROLONGED RELEASE MICROPARTICLE CONTAINING A MEDICINAL PRODUCT, PROCESS FOR THE PRODUCTION THEREOF, AND PREPARATION CONTAINING THE SAME MICROPARTICLE | |
| DE60121426D1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF LIVER INCARROSE AND LIVER FIBROSIS |